The GeneSearch™ BLN Assay represents a breakthrough in intra-operative testing to help reduce second surgeries and improve
overall quality of patient care. This advanced molecular technology offers objective and reproducible results. The test is FDA approved and is commercially available
in the US. The test is CE marked and is
commercially available in the EU. It is the first in a line of molecular products in development by Veridex.
|